GO:2001198 regulation of dendritic cell differentiation: Immune Cell Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001198 describes any process that modulates the frequency, rate or extent of dendritic cell differentiation, a central step in generating antigen-presenting cells.
• Dendritic cell differentiation is controlled by a multilayered network including growth factors, transcription factors, metabolic sensors, and signaling pathways such as Notch and Wnt.
• Metabolic regulation, especially via mTOR, is a critical determinant of dendritic cell differentiation and function.
• Genome-wide CRISPR screening has identified Trim33 as an essential regulator of dendritic cell differentiation, highlighting the power of unbiased approaches.
• Dysregulation of dendritic cell differentiation contributes to autoimmunity, cancer immune evasion, and impaired responses to infection.
• Experimental modeling of GO:2001198 benefits from knockout, knock-in, and overexpression cell systems combined with functional and multi-omic readouts.
Description
Dendritic cells (DCs) are specialized antigen-presenting cells that bridge innate and adaptive immunity, and their differentiation from hematopoietic progenitors is a tightly regulated process. The Gene Ontology term GO:2001198, regulation of dendritic cell differentiation, encompasses any process that modulates the frequency, rate or extent of dendritic cell differentiation. This term is essential for researchers because the number, subset composition, and functional state of DCs determine the quality of immune responses in homeostasis, infection, autoimmunity, and cancer. Understanding the regulatory inputs that control DC differentiation can reveal therapeutic targets and biomarkers for immune-mediated diseases.
regulation of dendritic cell differentiation At A Glance
| GO ID | GO:2001198 |
|---|---|
| GO term | regulation of dendritic cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of dendritic cell differentiation |
| Related processes | Dendritic cell lineage commitment, antigen presentation, immune tolerance, inflammation |
| Key regulators | mTOR, Notch, Wnt, Trim33, cytokines, metabolic pathways |
| Disease relevance | Autoimmunity, cancer, transplantation, infection |
What Is GO:2001198?
GO:2001198 is a biological process term defined as any process that modulates the frequency, rate or extent of dendritic cell differentiation. In other words, it covers all molecular and cellular events that positively or negatively influence the generation of dendritic cells from precursor cells, including cytokine signaling, transcription factor activity, metabolic cues, and cell-intrinsic checkpoints.
Why Is regulation of dendritic cell differentiation Important in Cell Biology?
Regulation of dendritic cell differentiation is fundamental to immune homeostasis and host defense because DCs are the primary initiators of T cell responses and tolerance. Perturbations in this process can lead to insufficient or excessive immune activation, contributing to autoimmunity, chronic inflammation, and failure to control tumors. Moreover, understanding how DC differentiation is regulated informs the development of vaccines, immunotherapies, and strategies for transplantation tolerance.
• Controls the generation of antigen-presenting cells that initiate adaptive immunity.
• Shapes central tolerance through thymic dendritic cell subsets.
• Influences autoimmune disease susceptibility and severity.
• Modulates anti-tumor immunity and response to immunotherapy.
• Integrates metabolic signals, such as mTOR activity, with immune cell fate.
• Involves evolutionarily conserved signaling pathways like Notch and Wnt.
• Provides targets for therapeutic manipulation in transplantation.
• Can be studied using genome-wide screens to uncover novel regulators.
• Dysregulation may contribute to immunodeficiency or immune evasion.
• Offers a paradigm for understanding how environmental cues reprogram cell fate.
What Happens During regulation of dendritic cell differentiation?
Hematopoietic precursor commitment
In simple terms: Stem cells decide to become dendritic cells.
Dendritic cells arise from hematopoietic stem and progenitor cells in the bone marrow and, for some subsets, in the thymus. Regulation of this early commitment step involves transcription factors and cytokine signals that bias progenitors toward the DC lineage. For example, Notch and Wnt pathways influence DC differentiation from precursors. The balance between self-renewal and differentiation is modulated by metabolic cues, including mTOR activity.
Cytokine and growth factor signaling
In simple terms: External signals tell cells to become dendritic cells.
Cytokines such as GM-CSF, Flt3L, and others provide critical signals that regulate the frequency and rate of DC differentiation. Vasoactive intestinal peptide (VIP) has been shown to regulate dendritic cell differentiation, with therapeutic implications for autoimmunity and transplantation. These signals activate intracellular cascades that converge on transcription factors controlling DC-specific gene expression.
Transcriptional control
In simple terms: Master switches inside the cell turn on dendritic cell genes.
Transcription factors such as IRF4, IRF8, PU.1, and Batf3 are known to control DC subset differentiation. Genome-wide screening identified Trim33 as an essential regulator of dendritic cell differentiation, acting likely through chromatin remodeling and transcriptional regulation. Notch and Wnt pathways also modulate transcriptional programs during DC differentiation.
Metabolic regulation
In simple terms: How cells use energy affects their ability to become dendritic cells.
Metabolic pathways, including glycolysis, oxidative phosphorylation, and lipid metabolism, regulate DC differentiation and function. mTOR, a central metabolic sensor, integrates nutrient and growth factor signals to control DC differentiation and function. This metabolic control ensures that DC development is coupled to the availability of energy and biosynthetic precursors.
Thymic regulation of DC subsets
In simple terms: The thymus also controls dendritic cell development for tolerance.
Intrathymic regulation of dendritic cell subsets is critical for central tolerance, as thymic DCs present self-antigens to developing T cells. This process involves distinct precursor populations and signals that differ from bone marrow DC development. Dysregulation can lead to autoimmunity due to impaired negative selection.
Key Genes Involved in GO:2001198 regulation of dendritic cell differentiation
The following genes and proteins have been experimentally implicated in the regulation of dendritic cell differentiation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Central metabolic sensor controlling DC differentiation and function | Target for metabolic regulation studies |
| TRIM33 | Essential regulator identified by genome-wide screen | Novel target for DC differentiation |
| NOTCH1 | Signaling pathway component regulating DC differentiation | Pathway analysis in DC development |
| WNT3A | Wnt pathway ligand influencing DC differentiation | Stem cell and DC differentiation studies |
| IRF8 | Transcription factor for DC subset specification | DC lineage commitment |
| IRF4 | Transcription factor for DC subset function | DC subset differentiation |
| BATF3 | Transcription factor for cDC1 development | Cross-presentation studies |
| SPI1 | Ets-family transcription factor (PU.1) for myeloid development | DC progenitor commitment |
| CSF2 | GM-CSF cytokine driving DC differentiation | In vitro DC generation |
| FLT3LG | Flt3 ligand supporting DC development | DC differentiation assays |
| VIP | Neuropeptide regulating DC differentiation | Autoimmunity and transplantation |
| ZBTB46 | Transcription factor marking conventional DCs | DC lineage tracing |
| ID2 | Inhibitor of DNA binding regulating DC subsets | DC development |
| TCF4 | Wnt pathway transcription factor | DC differentiation |
| LEF1 | Wnt pathway transcription factor | DC differentiation |
| HES1 | Notch target gene | DC differentiation |
| MYC | Metabolic and proliferation regulator | DC differentiation and metabolism |
How Is regulation of dendritic cell differentiation Regulated?
Regulation of dendritic cell differentiation is orchestrated by a network of extracellular cues and intracellular sensors. mTOR integrates nutrient and growth factor signals to control DC differentiation and function. Metabolic pathways, including glycolysis and oxidative phosphorylation, directly influence DC fate decisions. Notch and Wnt signaling pathways provide developmental cues that modulate DC differentiation. Additionally, genome-wide screens have revealed Trim33 as a critical regulator, suggesting chromatin-level control. Cytokines such as VIP further fine-tune DC differentiation with therapeutic implications.
regulation of dendritic cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Autoimmunity, cancer | Knockout or point-mutation cell lines |
| TRIM33 | Dendritic cell differentiation defects | Knockout and rescue models |
| VIP | Autoimmunity, transplantation | Overexpression or knockout models |
| NOTCH1 | Immune dysregulation | Knock-in reporter or knockout |
| IRF8 | DC subset deficiency | Knockout and overexpression |
Autoimmunity
Dysregulated dendritic cell differentiation can lead to altered tolerance and autoimmunity. VIP regulation of DC differentiation has therapeutic applications in autoimmunity and transplantation. Thymic DC subsets are critical for central tolerance, and their dysregulation may contribute to autoimmune diseases.
Cancer
Dendritic cell differentiation influences anti-tumor immunity. Molecular regulation of DC development in cancer can affect immune evasion and response to immunotherapy. Metabolic control of DC differentiation may also impact tumor microenvironment.
Transplantation
Manipulating DC differentiation can promote graft acceptance. VIP has been studied for therapeutic applications in transplantation through its effects on DC differentiation.
Infection and inflammation
Regulation of DC differentiation is crucial for mounting effective immune responses against pathogens. Inflammatory signals can alter DC differentiation pathways, impacting host defense.
From regulation of dendritic cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate DC differentiation? | Knockout cell line (e.g., CRISPR-Cas9) |
| Does a specific mutation affect DC differentiation? | Point-mutation knock-in |
| Does overexpression of gene Y enhance DC differentiation? | Overexpression cell model |
| How does gene Z affect DC subset composition? | Tagged knock-in for lineage tracing |
| What is the metabolic requirement for DC differentiation? | Metabolic perturbation with mTOR inhibitors |
| Which novel regulators control DC differentiation? | Genome-wide CRISPR library screening |
How to Study the regulation of dendritic cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for DC differentiation | Discovery of novel regulators |
| Flow cytometry | DC surface marker expression and frequency | Phenotypic characterization |
| RNA-seq | Transcriptional profiles | Gene expression changes |
| ATAC-seq | Chromatin accessibility | Regulatory element identification |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Metabolic regulation |
| Western blot | Protein expression and signaling | Pathway validation |
| ELISA | Cytokine production | Functional DC assays |
| Immunofluorescence | Protein localization | Cell imaging |
CRISPR screening
Genome-wide CRISPR screens can identify essential regulators of dendritic cell differentiation, as demonstrated by the discovery of Trim33. This approach enables unbiased discovery of novel genes and pathways.
Flow cytometry and cell sorting
Flow cytometry is used to quantify DC differentiation based on surface markers such as CD11c, MHC-II, and subset-specific markers. This method allows assessment of frequency and phenotype.
Transcriptomics and epigenomics
RNA-seq and ATAC-seq can reveal transcriptional and chromatin changes during DC differentiation. These methods help define regulatory networks and identify target genes.
Metabolic assays
Seahorse analysis, metabolomics, and nutrient tracing can measure metabolic fluxes during DC differentiation. These assays link metabolic state to differentiation outcomes.
How CRISPR Can Be Used to Study GO:2001198 regulation of dendritic cell differentiation
Knockout
CRISPR knockout of candidate genes in hematopoietic progenitors or DC cell lines can test their requirement for dendritic cell differentiation. For example, knockout of Trim33 impaired DC differentiation in a genome-wide screen. Knockout models are essential for establishing causality.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that affect protein function, such as in mTOR or transcription factors. These models help dissect domain-specific functions in DC differentiation.
Knock-in
Knock-in of reporter genes or tags allows tracking of DC differentiation in real time. For instance, tagging endogenous genes can reveal expression dynamics during differentiation.
Overexpression
Overexpression of regulatory genes, such as VIP or Notch components, can enhance or alter DC differentiation. This approach is useful for gain-of-function studies and therapeutic applications.
How EDITGENE Supports regulation of dendritic cell differentiation Research
Researchers studying regulation of dendritic cell differentiation-related genes often need to determine whether a candidate gene is causally involved in DC development, and what precise molecular function it exerts. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for regulation of dendritic cell differentiation research.
Frequently Asked Questions About regulation of dendritic cell differentiation
What is GO:2001198?
GO:2001198 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of dendritic cell differentiation.
What genes are involved in regulation of dendritic cell differentiation?
Key genes include MTOR, TRIM33, NOTCH1, WNT3A, IRF8, IRF4, BATF3, SPI1, CSF2, FLT3LG, VIP, ZBTB46, ID2, TCF4, LEF1, HES1, and MYC, among others.
How is dendritic cell differentiation regulated?
It is regulated by cytokines, transcription factors, metabolic sensors like mTOR, and signaling pathways such as Notch and Wnt.
What is the role of mTOR in dendritic cell differentiation?
mTOR integrates nutrient and growth factor signals to control dendritic cell differentiation and function.
What did the Trim33 screen reveal about dendritic cell differentiation?
A genome-wide screen identified Trim33 as an essential regulator of dendritic cell differentiation.
How does VIP regulate dendritic cell differentiation?
Vasoactive intestinal peptide (VIP) regulates dendritic cell differentiation and has therapeutic applications in autoimmunity and transplantation.
Why is regulation of dendritic cell differentiation important in cancer?
It influences anti-tumor immunity and response to immunotherapy, as molecular regulation of DC development affects immune evasion.
What methods are used to study regulation of dendritic cell differentiation?
Methods include CRISPR screening, flow cytometry, RNA-seq, ATAC-seq, metabolic assays, and Western blot.
Can CRISPR be used to study dendritic cell differentiation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect gene function in DC differentiation.
What are the therapeutic implications of targeting dendritic cell differentiation?
Modulating DC differentiation can be therapeutic in autoimmunity, transplantation, and cancer immunotherapy.
Conclusion
GO:2001198, regulation of dendritic cell differentiation, is a critical biological process that governs the generation of antigen-presenting cells essential for immune responses. Research has uncovered key roles for metabolic sensors like mTOR, signaling pathways such as Notch and Wnt, and novel regulators like Trim33. Understanding these mechanisms offers opportunities for therapeutic intervention in autoimmunity, cancer, and transplantation. EDITGENE provides advanced CRISPR tools to accelerate discovery in this field.
References
- 1. He Z et al.. 2019. Metabolic Regulation of Dendritic Cell Differentiation.. Front Immunol 10:410 PMID: 30930893
- 2. Chorny A et al.. 2006. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.. Ann N Y Acad Sci 1088:187-94 PMID: 17192565
- 3. Sukhbaatar N et al.. 2016. mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function.. Trends Immunol 37(11):778-789 PMID: 27614799
- 4. Tiniakou I et al.. 2024. Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation.. Sci Immunol 9(94):eadi1023 PMID: 38608038
- 5. Merad M et al.. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.. Annu Rev Immunol 31:563-604 PMID: 23516985
- 6. Calindi A et al.. 2025. Intrathymic Regulation of Dendritic Cell Subsets and Their Contributions to Central Tolerance.. Immunol Rev 332(1):e70039 PMID: 40433811
- 7. Cheng P et al.. 2010. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways.. Immunol Rev 234(1):105-19 PMID: 20193015
- 8. Chrisikos TT et al.. 2019. Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.. Mol Immunol 110:24-39 PMID: 29549977
